Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

The Odisha government is set to host the Odisha Pharma Summit 2025 on December 16. This event aims to unite stakeholders from the pharmaceutical and medical devices industries to explore new opportunities. Chief Minister Mohan Charan Majhi will inaugurate the programme. An official mentioned that the state will introduce the Odisha Pharmaceutical and Medical Devices Policy 2025 during this event.

The new policy is designed to attract investments, enhance business ease, and generate large-scale employment in the life sciences sector. Additionally, the government plans to announce the development of a Pharmaceutical Park and a Medical Devices Park. These initiatives aim to bolster the state’s healthcare manufacturing infrastructure and promote industry growth.

Focus on Industry Growth
Industries Minister Sampad Chandra Swain stated, “Odisha welcomes all pharma, medical devices & related sector industries, investors, and thought leaders to join us at this summit. We are committed to building a strong, future-ready ecosystem that supports growth, innovation, and global competitiveness.” The summit will also feature the signing of MoUs between the government and leading companies.

This collaboration marks a significant step towards enhancing the state’s pharmaceutical and medical devices ecosystem. The government encourages healthcare and industry enthusiasts to participate in this initiative, which aims to shape the future of the sector in Odisha.

The event’s agenda includes discussions on investment opportunities and strategies for improving business operations in the life sciences field. By bringing together industry leaders and investors, Odisha aims to position itself as a hub for pharmaceutical and medical device manufacturing.

Related Posts

After two years, pharma volumes pick up pace

NEW DELHI: The domestic pharmaceutical retail market is showing its strongest signs yet of a shift from price-led to demand-led growth. Volume growth crossed 3% in June, the first time…

NPPA fixes prices of 39 drugs, raises anti-rabies immunoglobulin rate

The National Pharmaceutical Pricing Authority (NPPA) has allowed an increase in the retail price of anti-rabies immunoglobulin while fixing the retail prices of 39 drug formulations.  According to a gazette…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

After two years, pharma volumes pick up pace

After two years, pharma volumes pick up pace

NPPA fixes prices of 39 drugs, raises anti-rabies immunoglobulin rate

NPPA fixes prices of 39 drugs, raises anti-rabies immunoglobulin rate

Tambaram police arrest two persons after seizing 1,100 banned tablets, 5 kg ganja

Tambaram police arrest two persons after seizing 1,100 banned tablets, 5 kg ganja

Rajasthan Healthcare Crisis: 8 Mothers Die Post-C-Section

Rajasthan Healthcare Crisis: 8 Mothers Die Post-C-Section

Steroid cream misuse fuels spurt in fungal infections

Steroid cream misuse fuels spurt in fungal infections

Dr Reddy’s delays semaglutide supplies due to API issue

Dr Reddy’s delays semaglutide supplies due to API issue